This podcast series from the Academy's Committee on Aging features leading experts who discuss clinical experiences and the differences in caring for older adults.

In today's podcast, Dr. Milam Brantley discusses the current landscape of research in age-related macular degeneration (AMD). Clinical work focuses on anti-VEGF treatment, refining delivery methods and developing new adjunct therapies to acheive the same or better response with lower cost and less treatment burden on patients.  Dry AMD remains an important second research arena as there is no effective treatment for halting the progression of geographic atrophy (GA). Dr. Brantley also discusses his own basic science research in metabolomics, through which he hopes to identify the metabolic and genetic profiles that predict an individual's disease course.

  Funded in part by the Retina Research Foundation